Skip to main content
. 2022 Jul 7;11(14):3949. doi: 10.3390/jcm11143949

Figure 1.

Figure 1

Timeline of two study cohorts of COVID-19. Patients from March to December 2020 were used for the training cohort, whereas patients from January to September 2021 were used for the validation cohort. The incidence of VTE was 7.8% in the derivation cohort and 7.3% in the validation cohort. Abbreviation: VTE, venous thromboembolism.